Acanthopanax trifoliatus (L.) Merr polysaccharides ameliorates hyperglycemia by regulating hepatic glycogen metabolism in type 2 diabetic mice
Open Access
- 9 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 10, 1111287
Abstract
Introduction: Drug monotherapy was inadequate in controlling blood glucose levels and other comorbidities. An agent that selectively tunes multiple targets was regarded as a new therapeutic strategy for type 2 diabetes. Acanthopanax trifoliatus (L.) Merr polysaccharide (ATMP) is a bio-macromolecule isolated from Acanthopanax trifoliatus (L.) Merr and has therapeutic potential for diabetes management due to its anti-hyperglycemia activity.Methods: Type 2 diabetes mellitus was induced in mice using streptozotocin, and 40 and 80 mg/kg ATMP was administered daily via the intragastric route for 8 weeks. Food intake, water intake, and body weight were recorded. The fasting blood glucose (FBG), fasting insulin (FINS) and an oral glucose tolerance test (OGTT) were performed. Histological changes in the liver and pancreas were analyzed by H&E staining. The mRNA and the protein levels of key factors involved in glycogen synthesis, glycogenolysis, and gluconeogenesis were measured by quantitative real time PCR and Western blotting.Results: In this study, we found that ATMP could effectively improve glucose tolerance and alleviate insulin resistance by promoting insulin secretion and inhibiting glucagon secretion. In addition, ATMP decreases glycogen synthesis by inhibiting PI3K/Akt/GSK3β signaling, reduces glycogenolysis via suppressing cAMP/PKA signaling, and suppresses liver gluconeogenesis by activating AMPK signaling.Conclusion: Together, ATMP has the potential to be developed as a new multitargets therapeutics for type 2 diabetes.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2017A030313623)
This publication has 50 references indexed in Scilit:
- Lifestyle Weight-Loss Intervention Outcomes in Overweight and Obese Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsJournal of the Academy of Nutrition and Dietetics, 2015
- Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytesClinical Science, 2015
- Anticancer Activity of Acanthopanax trifoliatus (L) Merr Extracts is Associated with Inhibition of NF-κB Activity and Decreased Erk1/2 and Akt PhosphorylationAsian Pacific Journal of Cancer Prevention, 2014
- AMPK activation: a therapeutic target for type 2 diabetes?Diabetes, Metabolic Syndrome and Obesity, 2014
- A Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen DepositionCell Metabolism, 2013
- Anti-inflammatory and anti-hyperalgesic activities of Acanthopanax trifoliatus (L) Merr leavesPharmacognosy Research, 2013
- Insulin and Glucagon Regulate Pancreatic α-Cell ProliferationPLOS ONE, 2011
- Antioxidant Activity of Acanthopanax trifoliatusMedical Principles and Practice, 2009
- The Effects of Streptozotocin-induced Diabetes and Insulin Supplementation on Expression of the Glycogen Phosphorylase Gene in Rat LiverJournal of Biological Chemistry, 1995
- Medicinal plants of East and Southeast Asia: Attributed properties: by Lily M. Perry (assisted by Judith Metzger), published by Massachusetts Institute of Technology Press, Cambridge, MA, 1980; price $45.00Journal of Ethnopharmacology, 1981